United Health Products (UEEC) Stock Price, News & Analysis

Company Overview

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.

Key Stats

• Today's Range: $0.26 to $0.28
• 50-Day Range: $0.12 to $0.27
• 52-Week Range: $0.05 to $0.28
• Volume: 25,088 shs
• Average Volume: 125,908 shs
• Market Capitalization: $69.16 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

United Health Products Stock Analysis - MarketRank™

United Health Products scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for United Health Products.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of United Health Products is -27.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of United Health Products is -27.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of United Health Products has been sold short.

Short Interest Ratio / Days to Cover

United Health Products has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in United Health Products has recently increased by 9.76%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

United Health Products does not currently pay a dividend.

Dividend Growth

United Health Products does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.01% of the float of United Health Products has been sold short.

Short Interest Ratio / Days to Cover

United Health Products has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in United Health Products has recently increased by 9.76%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 4.0 / 5
• News Sentiment: N/A

News Sentiment

United Health Products has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.92 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for United Health Products this week, compared to 0 articles on an average week.

Search Interest

2 people have searched for UEEC on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added United Health Products to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, United Health Products insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.50% of the stock of United Health Products is held by insiders.

Percentage Held by Institutions

Only 0.07% of the stock of United Health Products is held by institutions.

UEEC Stock Analysis - Frequently Asked Questions

How have UEEC shares performed this year?

United Health Products' stock was trading at $0.0531 at the start of the year. Since then, UEEC shares have increased by 408.5% and is now trading at $0.27.
View the best growth stocks for 2025 here.

How were United Health Products' earnings last quarter?

United Health Products, Inc. (OTCMKTS:UEEC) announced its quarterly earnings results on Friday, March, 28th. The company reported ($0.01) EPS for the quarter.

How do I buy shares of United Health Products?

Shares of UEEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of United Health Products own?

Based on aggregate information from My MarketBeat watchlists, some other companies that United Health Products investors own include UnitedHealth Group (UNH), Bank of America (BAC), NVIDIA (NVDA), Quantum Materials (QTMM), Salesforce (CRM), Cisco Systems (CSCO) and Johnson & Johnson (JNJ).

Company Calendar

• Last Earnings: 3/28/2025
• Today: 4/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:UEEC
• CIK: 1096938
• Web: www.unitedhealthproductsinc.com
• Phone: (475) 755-1005
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-2,620,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -840.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.03
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: $40,000.00
• Price / Sales: 1,729.07
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.01) per share
• Price / Book: -27.00

Miscellaneous

• Outstanding Shares: 256,158,000
• Free Float: 246,332,000
• Market Cap: $69.16 million
• Optionable: Not Optionable
• Beta: -1.25